Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
United States District Court, Southern District of CaliforniaFebruary 1, 20233:22-cv-00676California1,107 words
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 FATE THERAPEUTICS, INC.; and Case No.: 22-cv-00676-H-MSB
WHITEHEAD INSTITUTE FOR
BIOMEDICAL RESEARCH, ORDER:
13 Plaintiffs, (1) GRANTING DEFENDANTS’ 14 v. MOTIONS TO FILE DOCUMENTS UNDER SEAL; SHORELINE BIOSCIENCES, INC.; and
DAN S. KAUFMAN, [Doc. Nos. 119, 122, 125, 138.] Defendants. (2) DIRECTING THE CLERK TO
FILE THE PROPOSED
DOCUMENTS UNDER SEAL ; AND
[Doc. Nos. 120, 123, 126, 139.]
22 (3) ORDERING DEFENDANT KAUFMAN TO PUBLICLY FILE
DOCKET ENTRY NO. 140
On January 27, 2023, Defendant Shoreline Biosciences, Inc. (“Shoreline”) filed a motion to partially dismiss Plaintiffs’ first amended complaint pursuant to Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim. (Doc. No. 121.) On January 27, 2023, Shoreline also filed a motion to file under seal…